|
|
|
Insider
Information: |
Shoemaker Daniel D |
Relationship: |
Chief Scientific Officer |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
73,020 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$266,523 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
73,020 |
|
|
Total
Value |
$266,523 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-10.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Fate Therapeutics Inc |
FATE |
Chief Scientific Officer |
2021-03-08 |
73,020 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2021-03-08 |
4 |
AS |
$78.60 |
$2,043,428 |
D/D |
(25,000) |
73,020 |
0 |
% |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
14,411 |
98,020 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2021-01-11 |
4 |
S |
$109.65 |
$360,477 |
D/D |
(3,253) |
83,609 |
0 |
% |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2021-01-08 |
4 |
S |
$114.76 |
$729,434 |
D/D |
(6,229) |
86,862 |
0 |
% |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2020-11-16 |
4 |
AS |
$50.37 |
$1,295,746 |
D/D |
(25,000) |
93,091 |
0 |
% |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2020-09-14 |
4 |
AS |
$35.40 |
$907,540 |
D/D |
(25,000) |
118,091 |
0 |
% |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2020-01-08 |
4 |
S |
$20.70 |
$117,986 |
D/D |
(5,700) |
143,091 |
0 |
% |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2020-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
148,791 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2019-12-30 |
4 |
AS |
$19.49 |
$487,427 |
D/D |
(25,000) |
123,791 |
0 |
% |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2019-12-30 |
4 |
OE |
$2.90 |
$72,500 |
D/D |
25,000 |
148,791 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2019-10-15 |
4 |
S |
$14.29 |
$168,593 |
D/D |
(11,800) |
123,791 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2019-06-27 |
4 |
AS |
$20.21 |
$252,610 |
D/D |
(12,500) |
135,591 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2019-06-27 |
4 |
OE |
$2.90 |
$36,250 |
D/D |
12,500 |
148,091 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2019-03-28 |
4 |
AS |
$16.94 |
$211,703 |
D/D |
(12,500) |
135,591 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2019-03-28 |
4 |
OE |
$2.90 |
$36,250 |
D/D |
12,500 |
148,091 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2019-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
135,591 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2017-10-16 |
4 |
S |
$4.08 |
$2,856 |
D/D |
(700) |
90,591 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2017-10-13 |
4 |
S |
$3.86 |
$48,347 |
D/D |
(12,525) |
91,291 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2016-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,388 |
103,816 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Scientific Officer |
|
2015-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
66,000 |
94,428 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Research Officer |
|
2015-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,466 |
28,428 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Technology Officer |
|
2014-03-31 |
4 |
AS |
$9.83 |
$85,361 |
D/D |
(8,653) |
25,962 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Chief Technology OfficerOffice |
|
2013-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,615 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|